The DOI matches its Crossref record; 324 of the 330 references it cites were found in a registry or an index; 24 of the 49 sources its claims cite were checked for support.
Molecular diagnostics in cerebrospinal fluid for the diagnosis of central nervous system infections
Open accessAbstract
SUMMARYCentral nervous system (CNS) infections can be caused by various pathogens, including bacteria, viruses, fungi, and parasites. Molecular diagnostic methods are pivotal for identifying the different causative pathogens of these infections in clinical settings. The efficacy and specificity of these methods can vary per pathogen involved, and in a substantial part of patients, no pathogen is identified in the cerebrospinal fluid (CSF). Over recent decades, various molecular methodologies have been developed and applied to patients with CNS infections. This review provides an overview of the accuracy of nucleic acid amplification methods in CSF for a diverse range of pathogens, examines the potential value of multiplex PCR panels, and explores the broad-range bacterial and fungal PCR/sequencing panels. In addition, it evaluates innovative molecular approaches to enhance the diagnosis of CNS infections.
Overview
CoChat Summary
TL;DR
This review summarizes nucleic acid amplification testing (NAAT) in cerebrospinal fluid (CSF) for central nervous system (CNS) infections, covering pathogen-specific PCR, multiplex panels, broad-range PCR/sequencing, and metagenomic next-generation sequencing (mNGS). It reports generally high sensitivity and specificity for many pathogens but notes persistent diagnostic gaps, especially culture-negative cases and low-sensitivity assays such as those for *Mycobacterium tuberculosis*.
Key findings
- For *Streptococcus pneumoniae*, CSF PCR sensitivity reached a median of 100% (range 79%–100%) and specificity a median of 98% (range 93%–100%); for *Neisseria meningitidis*, median sensitivity was 97% (range 91%–100%) and median specificity 96% (range 91%–100%), with PCR increasing cause-specific diagnosis by 13%–61% (median 59%) in culture-negative cases.
- For *Haemophilus influenzae*, *bexA* PCR had median sensitivity 93% (range 81%–100%) and median specificity 94% (range 81%–100%); for *Mycobacterium tuberculosis*, IS6110 PCR had median sensitivity 91% (range 72%–100%) and median specificity 99% (range 82%–100%), while GeneXpert pooled sensitivity was 71% (95% CI 63–79) and Xpert Ultra sensitivity was 89% (95% CI 79–96).
- For *Streptococcus suis* serotype 2, *cps2J* PCR showed 100% sensitivity (95% CI 97%–100%) and 100% specificity (95% CI 96%–100%), and adding PCR increased diagnostic yield by 84% in one population.
- Multiplex PCR panels can detect multiple pathogens in one assay, but validation studies show both false-negative and false-positive results depending on the pathogen; broad-range 16S/18S/28S/ITS PCR/sequencing and mNGS offer unbiased detection but risk contamination and are not routine in most laboratories.
Methods
- Design: narrative review of molecular diagnostics in CSF for CNS infections, including pathogen-specific NAAT, multiplex PCR panels, broad-range bacterial/fungal/parasitic PCR/sequencing, and mNGS.
- Data/sample: published studies and validation cohorts of patients with suspected CNS infection, with reported sample sizes ranging from small case series (e.g., 3–6 patients for *Tropheryma whipplei* or *Brucella*) to larger cohorts (e.g., 827 patients with suspected bacterial meningitis for group B *Streptococcus* PCR).
- Main analysis: qualitative synthesis of sensitivity, specificity, and incremental diagnostic yield compared with culture or conventional diagnostics, with results presented in tables and supplemental material.
Limitations
- The paper states that PCR requires prior knowledge of the target sequence, is pathogen-specific, can produce false-positive results from DNA contamination, and can produce false-negative results when DNA concentration is too low; multiplex panels may yield false-positive and false-negative results depending on the pathogen.
- The paper states that some pathogen-specific evidence is limited by small sample sizes and lack of adequately powered studies, such as for *Brucella* spp. and *Tropheryma whipplei*.
- Evident from the text: the review is narrative and does not report a systematic search strategy, risk-of-bias assessment, or meta-analytic pooling in the available text; the provided text is also truncated, so later pathogen sections and conclusions are not available for summary.
Model-written summary of a shortened version of the paper’s full text (it is longer than we read). Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
11 Valid · 2 Not valid · 1 Not checked · 1 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“By sequencing all genetic material, both DNA and RNA after conversion into cDNA, in a sample, it is theoretically able to detect all potential pathogens in one assay (43).”
What the sources say
- Supportedcites [43] source
The Introduction describes the capacity to detect all potential pathogens in a sample. The Infectious disease diagnosis section explains that untargeted mNGS sequences DNA and RNA after reverse transcription to cDNA, supporting the claimed basis for detection in one assay. (LLM, conf=0.93)
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“However, several validation studies have shown that, depending on the causative pathogen, both false-negative and false-positive results are of concern—the use of multiplex PCR panels in clinical practice is discussed later in this review (32).”
What the sources say
- Supportedcites [32] source
The Discussion reports that FA/ME panel performance varies among microorganisms, identifies suboptimal sensitivity for several pathogens, and cautions about false positives, particularly when CNS infection prevalence is low. The Results also quantify false-positive findings. Together, these support the concern about both false-negative and false-positive results, while the evidence is specifically about the FA/ME panel. (LLM, conf=0.90)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The addition of PCR in this population increased the diagnostic yield for S. suis meningitis by 84%.”
What the sources say
- Supportedcites [80] source
The Discussion explicitly states that PCR increased diagnostic yield by 84% for patients with S. suis serotype 2 infection. The Results report 101 PCR-positive samples versus 55 culture-positive samples among the prospectively studied patients, consistent with that increase. (LLM, conf=0.95)
plainstates a causen = 238- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
In the paper
“Since its implementation, molecular diagnostics have become the gold standard for demonstrating viral DNA or RNA in the CSF (15).”
What the sources say
- Not checked — no full text of the sourcecites [15] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- It may state two separate claims as one. 10
- Probably not a substantial claim. 3
Citations
Cites
Loop-mediated isothermal amplification of DNA
Notomi, T. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.12.e63 · Cited by 8,805 · cited 1×
“LAMP uses four to six primer pairs to detect six to eight sequences of the target DNA and the reaction only occurs when all regions are recognized correctly by the primers, which leads to a highly specific assay (21, 22).”
Schoch, C. L., Seifert, K. A., Huhndorf, S., Robert, V., Spouge, J. L., Levesque, C. A., Chen, W., Fungal Barcoding Consortium, Fungal Barcoding Consortium Author List, Bolchacova, E., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117018109 · Cited by 5,120
Clarridge, J. E. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.4.840-862.2004 · Cited by 2,148 · cited 2×
“For bacteria, the 16S ribosomal RNA gene is a highly con served gene that is present in almost all bacteria and can therefore be used as a universal bacterial target (33).”
Clinical features and prognostic factors in adults with bacterial meningitis
van de Beek, D., de Gans, J., Spanjaard, L., Weisfelt, M., Reitsma, J. B., & Vermeulen, M. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040845 · Cited by 1,639
Chiu, C. Y., & Miller, S. A. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-019-0113-7 · Cited by 1,620 · cited 3×
“By sequencing all genetic material, both DNA and RNA after conversion into cDNA, in a sample, it is theoretically able to detect all potential pathogens in one assay (43).”
Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
Bloomgren, G., Richman, S., Hotermans, C., Subramanyam, M., Goelz, S., Natarajan, A., Lee, S., Plavina, T., Scanlon, J. V., Sandrock, A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1107829 · Cited by 1,242 · cited 1×
“PML due to JC virus activation is most common in HIV patients or patients that are treated with certain immunosuppressive drugs, most commonly the monoclonal antibody natalizumab (248).”
Yang, S., & Rothman, R. E. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01044-8 · Cited by 1,112 · cited 3×
“The most common and broadly used nucleic acid amplification testing (NAAT) is the PCR. PCR is a technique that can target a specific DNA sequence of a certain pathogen using specific primers (16).”
Lanciotti, R. S., Kerst, A. J., Nasci, R. S., Godsey, M. S., Mitchell, C. J., Savage, H. M., Komar, N., Panella, N. A., Allen, B. C., Volpe, K. E., et al. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.11.4066-4071.2000 · Cited by 1,087
Clinical Metagenomic Sequencing for Diagnosis of Meningitis and Encephalitis
Wilson, M. R., Sample, H. A., Zorn, K. C., Arevalo, S., Yu, G., Neuhaus, J., Federman, S., Stryke, D., Briggs, B., Langelier, C., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1803396 · Cited by 1,067 · cited 2×
“Another limitation of mNGS can be that some pathogens may go undetected due to low amount of DNA or RNA in the CSF (44, 310).”
Actionable Diagnosis of Neuroleptospirosis by Next-Generation Sequencing
Wilson, M. R., Naccache, S. N., Samayoa, E., Biagtan, M., Bashir, H., Yu, G., Salamat, S. M., Somasekar, S., Federman, S., Miller, S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1401268 · Cited by 977 · cited 1×
“The first clinical application of mNGS in CNS infections was described in 2014, when a case of neuroleptospirosis was detected by mNGS (309).”
Research works printed but not linked: 1
- Anonymous. 2011. Laboratory methods for the diagnosis of meningitis caused by Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae: WHO manual. 2nd ed. World Health Organization.
Cited by
Neurobrucellosis: a retrospective cohort of 106 patients
Arazi, F., Haddad, M., Sheybani, F., et al. (2025) · Tropical Medicine and Health · doi:10.1186/s41182-025-00680-1 · Cited by 18
“However, despite its promise, there is still a lack of sufficiently powered studies to confirm its effectiveness [26].”
Diagnosing infectious encephalitis: a narrative review
Olie, S. E., Staal, S. L., van de Beek, D., & Brouwer, M. C. (2024) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2024.11.026 · Cited by 26
Self-citationOlie, S. E., Staal, S. L., Groeneveld, N. S., Schotman, H. H. M., Bodilsen, J., Nielsen, H., Bijlsma, M. W., van de Beek, D., & Brouwer, M. C. (2025) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2025.101309 · Cited by 10
“4,10 Therefore, there is an ongoing need for innovative approaches to facilitate the rapid and accurate identi fi cation of bacterial meningitis.”
Self-citationRevisiting diagnostics: rapid diagnosis of neurological infections
Smit, L. F. E., Wessels, E., Boers, S. A., & Claas, E. C. J. (2025) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2025.01.020 · Cited by 3
Liotti, F. M., Posteraro, B., Sanguinetti, M., & Angelis, G. D. (2026) · MicrobiologyOpen · doi:10.1002/mbo3.70079 · Cited by 2
“Many pathogens that can cause CNS infections are not currently covered by multiplex assays (Olie et al. 2024), which further limits their standalone use.”
Metadata
- Authors
- Olie, S. E., Andersen, C. Ø., van de Beek, D., & Brouwer, M. C.
- Affiliations
- Amsterdam Neuroscience (NL)
- Statens Serum Institut (DK)
- Department of Neurology, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience
- Corresponding author
- Brouwer, Matthijs C.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2024-12-10
- Volume
- 37
- Issue
- 4
- Pages
- e0002124-e0002124
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- PMC
- PMC11629637
- OpenAlex
- W4403406701
- Cited by
- 38
- References
- 330
- Citations by year
- 2026: 28 · 2025: 9 · 2024: 1
- FWCI
- 2.10
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-sa
- doi.org/10.1128/ASMCopyrightv2 (vor)
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Clinical Microbiology Reviews (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (submittedVersion, other-oa)
- Funders
- EC | European Research Council (101001237)
- Topics
- Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Keywords
- central nervous system infection, cerebrospinal fluid, molecular diagnosis, nucleic acid amplification, multiplex PCR panels, pathogen identification, bacterial meningitis, viral meningitis, fungal meningitis, parasitic meningitis
- MeSH terms
- Bacteria, Central Nervous System Infections, Cerebrospinal Fluid, Humans, Viruses, Nucleic Acid Amplification Techniques, Molecular Diagnostic Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Molecular diagnostics in cerebrospinal fluid for the diagnosis of central nervous system infections. https://app.cochat.ai/papers/10.1128/cmr.00021-24
- The paper
- Olie, S. E., Andersen, C. Ø., van de Beek, D., & Brouwer, M. C. (2024). Molecular diagnostics in cerebrospinal fluid for the diagnosis of central nervous system infections. Clinical Microbiology Reviews. https://doi.org/10.1128/cmr.00021-24
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.